• Marko Kornmann


Global cancer incidence is going to increase almost 50% within the next two decades with a predicted rise to 28.4 million new cases in 2040[1]. Although cancer survivorship could be improved for all entities to over 60% between 2010 to 2020[2], malignancies of the gastrointestinal (GI) system are becoming an even greater problem. In fact, out of the 10 million cancer deaths observed in 2020 more than 40% of them are due to gastrointestinal malignancies including cancers of the esophagus, stomach, liver, pancreas, colon, and rectum1. In particular, pancreatic cancer is predicted to overtake colorectal, prostate, and breast cancer to rank as the second place in cancer related deaths in 2030[3].




How to Cite

Kornmann, M. (2023). Editorial. Translational Surgical Oncology, 1(1), 1–2. Retrieved from https://translsuronco.org/index.php/tso/article/view/7603